Literature DB >> 22707127

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011.

Andrea Antinori1, Simone Marcotullio, Adriana Ammassari, Massimo Andreoni, Gioacchino Angarano, Orlando Armignacco, Giampiero Carosi, Paola Cinque, Antonella d'Arminio Monforte, Giovanni Di Perri, Barbara Ensoli, Marco Floridia, Massimo Galli, Claudio Mastroianni, Alberto Matteelli, Francesco Mazzotta, Mauro Moroni, Giorgio Pal, Massimo Puoti, Vincenzo Puro, Giuliano Rizzardini, Evangelista Sagnelli, Stefano Vella, Vincenzo Vullo, Adriano Lazzarin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22707127

Source DB:  PubMed          Journal:  New Microbiol        ISSN： 1121-7138            Impact factor:   2.479


× No keyword cloud information.
  10 in total

Review 1.  Diagnosis and management of lymphomas and other cancers in HIV-infected patients.

Authors:  Antonino Carbone; Emanuela Vaccher; Annunziata Gloghini; Liron Pantanowitz; Akin Abayomi; Paolo de Paoli; Silvia Franceschi
Journal:  Nat Rev Clin Oncol       Date:  2014-03-11       Impact factor: 66.675

Review 2.  Treatment optimization in patients co-infected with HIV and Mycobacterium tuberculosis infections: focus on drug-drug interactions with rifamycins.

Authors:  Mario Regazzi; Anna Cristina Carvalho; Paola Villani; Alberto Matteelli
Journal:  Clin Pharmacokinet       Date:  2014-06       Impact factor: 6.447

3.  Taming HIV-related inflammation with physical activity: a matter of timing.

Authors:  Gabriella d'Ettorre; Giancarlo Ceccarelli; Noemi Giustini; Claudio M Mastroianni; Guido Silvestri; Vincenzo Vullo
Journal:  AIDS Res Hum Retroviruses       Date:  2014-09-17       Impact factor: 2.205

Review 4.  Pharmacokinetics and pharmacodynamics of antiretrovirals in the central nervous system.

Authors:  Andrea Calcagno; Giovanni Di Perri; Stefano Bonora
Journal:  Clin Pharmacokinet       Date:  2014-10       Impact factor: 6.447

5.  Risk factors for early mortality after AIDS in the cART era: A population-based cohort study in Italy.

Authors:  Barbara Suligoi; Antonella Zucchetto; Enrico Grande; Laura Camoni; Luigino Dal Maso; Luisa Frova; Saverio Virdone; Stefano Boros; Marilena Pappagallo; Martina Taborelli; Vincenza Regine; Paolo De Paoli; Diego Serraino
Journal:  BMC Infect Dis       Date:  2015-06-12       Impact factor: 3.090

Review 6.  Economic evaluation of initial antiretroviral therapy for HIV-infected patients: an update of Italian guidelines.

Authors:  Giorgio L Colombo; Sergio Di Matteo; Andrea Antinori; Massimo Medaglia; Silvia Murachelli; Giuliano Rizzardini
Journal:  Clinicoecon Outcomes Res       Date:  2013-10-03

Review 7.  Guidelines for Evaluation and Management of Cognitive Disorders in HIV-Positive Individuals.

Authors:  Jonathan Underwood; Alan Winston
Journal:  Curr HIV/AIDS Rep       Date:  2016-10       Impact factor: 5.071

8.  Demographical, Viro-Immunological, Clinical and Therapeutical Characteristics of HIV-Infected Patients in an "Epidemiologically Unexplored" Region of Italy (Calabria Region): the CalabrHIV Cohort.

Authors:  Maria Concetta Postorino; Filippo Luciani; Carmelo Mangano; Maria Stella Carpentieri; Paolo Scerbo; Armando Priamo; Giuseppina Berardelli; Roberto Marino; Alfredo Vallone; Nicola Serrao; Vincenzo Pisani; Chiara Costa; Albano Terremoto; Giuseppe Foti; Lucio Cosco; Massimo Calderazzo; Domenico Corigliano; Preziosa Scordo; Alessio Strazzulla; Carlo Torti
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-10-08       Impact factor: 2.576

9.  Timing of antiretroviral therapy initiation after a first AIDS-defining event: temporal changes in clinical attitudes in the ICONA cohort.

Authors:  Antonella Cingolani; Alessandro Cozzi-Lepri; Adriana Ammassari; Cristina Mussini; Maria Alessandra Ursitti; Pietro Caramello; Gioacchino Angarano; Paolo Bonfanti; Andrea De Luca; Maria Stella Mura; Enrico Girardi; Andrea Antinori; Antonela D'Arminio Monforte
Journal:  PLoS One       Date:  2014-02-27       Impact factor: 3.240

10.  Cost analysis of initial highly active antiretroviral therapy regimens for managing human immunodeficiency virus-infected patients according to clinical practice in a hospital setting.

Authors:  Giorgio L Colombo; Antonella Castagna; Sergio Di Matteo; Laura Galli; Giacomo Bruno; Andrea Poli; Stefania Salpietro; Alessia Carbone; Adriano Lazzarin
Journal:  Ther Clin Risk Manag       Date:  2013-12-18       Impact factor: 2.423
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.